Development of a next-generation ACE2-Fc formulation for SARS-CoV-2 mutant strains

Risa Takada

[3SP-21-13] Development of a next-generation ACE2-Fc formulation for SARS-CoV-2 mutant strains

^○Risa Takada¹, Haruna Ogami², Kyosuke Suzuki², Kenji Ishimoto^1,3, Kazumasa Ohtake⁴, Kensaku Sakamoto⁴, Yasuo Yoshioka⁵, Shinsaku Nakagawa^1,3, Nobumasa Hino¹ (1.Grad. Sch. Pharm. Sci., Osaka Univ., 2.Sch. Pharm. Sci., Osaka Univ., 3.Global Ctr. for Med. Eng. Inform., Osaka Univ., 4.RIKEN RBD, 5.RIMD, Osaka Univ.)

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3SP-21-13] Development of a next-generation ACE2-Fc formulation for SARS-CoV-2 mutant strains

Password